Home
News
Create
Screeners
Insights
Ganga Pharmaceuticals
12.
00
-12.00
(-100.00%)
Market Cap
₹7.10 Cr
PE Ratio
488.20
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Ganga Pharmaceuticals
Ganga Pharmaceuticals Limited Re-appoints Managing Director for Three-Year Term
5 days ago
Ganga Pharmaceuticals Limited's board has approved the re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for another three-year term effective April 01, 2026. The decision, made during a board meeting on March 10, 2026, was based on recommendations from the Nomination and Remuneration Committee and Audit Committee, with proper regulatory filings made pursuant to SEBI Listing Regulations.
Ganga Pharmaceuticals Reports Decline in Revenue and Profit for H1 FY2026
Nov 07, 2025
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Sep 19, 2025
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Aug 05, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO